20-64098224-C-T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_182647.4(OPRL1):c.590-52C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.144 in 1,601,752 control chromosomes in the GnomAD database, including 17,189 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.14   (  1541   hom.,  cov: 32) 
 Exomes 𝑓:  0.14   (  15648   hom.  ) 
Consequence
 OPRL1
NM_182647.4 intron
NM_182647.4 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -1.31  
Publications
8 publications found 
Genes affected
 OPRL1  (HGNC:8155):  (opioid related nociceptin receptor 1) The protein encoded by this gene is a member of the 7 transmembrane-spanning G protein-coupled receptor family, and functions as a receptor for the endogenous, opioid-related neuropeptide, nociceptin/orphanin FQ. This receptor-ligand system modulates a variety of biological functions and neurobehavior, including stress responses and anxiety behavior, learning and memory, locomotor activity, and inflammatory and immune responses. A promoter region between this gene and the 5'-adjacent RGS19 (regulator of G-protein signaling 19) gene on the opposite strand functions bi-directionally as a core-promoter for both genes, suggesting co-operative transcriptional regulation of these two functionally related genes. Alternatively spliced transcript variants have been described for this gene. A recent study provided evidence for translational readthrough in this gene, and expression of an additional C-terminally extended isoform via the use of an alternative in-frame translation termination codon. [provided by RefSeq, Dec 2017] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85). 
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.148  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.141  AC: 21444AN: 152084Hom.:  1540  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
21444
AN: 
152084
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD4 exome  AF:  0.145  AC: 209855AN: 1449550Hom.:  15648  Cov.: 33 AF XY:  0.144  AC XY: 103543AN XY: 719616 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
209855
AN: 
1449550
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
103543
AN XY: 
719616
show subpopulations 
African (AFR) 
 AF: 
AC: 
4721
AN: 
33194
American (AMR) 
 AF: 
AC: 
3274
AN: 
44084
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
4711
AN: 
25368
East Asian (EAS) 
 AF: 
AC: 
3261
AN: 
39536
South Asian (SAS) 
 AF: 
AC: 
10479
AN: 
84934
European-Finnish (FIN) 
 AF: 
AC: 
7601
AN: 
52086
Middle Eastern (MID) 
 AF: 
AC: 
631
AN: 
5718
European-Non Finnish (NFE) 
 AF: 
AC: 
166498
AN: 
1104790
Other (OTH) 
 AF: 
AC: 
8679
AN: 
59840
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.501 
Heterozygous variant carriers
 0 
 11864 
 23728 
 35592 
 47456 
 59320 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 5914 
 11828 
 17742 
 23656 
 29570 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.141  AC: 21448AN: 152202Hom.:  1541  Cov.: 32 AF XY:  0.139  AC XY: 10330AN XY: 74420 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
21448
AN: 
152202
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
10330
AN XY: 
74420
show subpopulations 
African (AFR) 
 AF: 
AC: 
5809
AN: 
41514
American (AMR) 
 AF: 
AC: 
1570
AN: 
15306
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
678
AN: 
3468
East Asian (EAS) 
 AF: 
AC: 
452
AN: 
5168
South Asian (SAS) 
 AF: 
AC: 
630
AN: 
4828
European-Finnish (FIN) 
 AF: 
AC: 
1588
AN: 
10604
Middle Eastern (MID) 
 AF: 
AC: 
32
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
10212
AN: 
67994
Other (OTH) 
 AF: 
AC: 
312
AN: 
2114
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.500 
Heterozygous variant carriers
 0 
 918 
 1836 
 2753 
 3671 
 4589 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 236 
 472 
 708 
 944 
 1180 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
381
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.